...PLYMOUTH Mass. April 20 2011 /- Harvest Technologies C...The trial is intended to evaluate the safety and clinical effect of Ha...Congestive Heart Failure is a persistent and relentless problem which...While there are several cardiac trials that have shown a clinical effe...

PLYMOUTH, Mass., April 20, 2011 /PRNewswire/ -- Harvest Technologies Corp. (www.harvesttech.com) announced today that the first twelve patients of its sixty patient Heart Failure trial have been enrolled at Medanta-the Medicity in Gurgaon INDIA.

The trial is intended to evaluate the safety and clinical effect of Harvest's BMAC autologous cell composition to treat patients with Congestive Heart Failure (CHF) when using a minimally invasive retrograde coronary sinus delivery. This is a randomized, controlled design treating both ischemic and non-ischemic heart failure patients. Patient enrollment will take place in sites in India, Germany and Peru and will feature electronic data entry with its data coordinating center at the University of Utah. The overall trial will be directed by Amit Patel, MD, Director, Center for Cardiac Cell Therapy at the University of Utah. The trial is being conducted in compliance with the United States FDA clinical trial regulations, ICH GCP, local IRB or IEC regulations and the "Declaration of Helsinki" and a Data Safety Monitoring Board (DSMB) will monitor adverse events.

Congestive Heart Failure is a persistent and relentless problem, which affects over an estimated 20 million patients world-wide. It occurs when the heart's ability to pump blood is so impaired that "systemic perfusion is inadequate to meet the body's demands" and this condition cannot be mediated by either by medication or surgical or endovascular intervention. A major advance in treatment is needed which could reverse this condition and in ischemic patients initiate neovascularization to restore perfusion within the affected area of the myocardium.

While there are several cardiac trials that have shown a clinical effect arising from the delivery of bone marrow cells through the coronaries, this approach offers several advantages according to Dr. Patel. "This novel deliver'/>"/>

(Date:3/30/2015)... Multiple new research abstracts suggest walnuts may have ... From their impact on colon cancer and certain aspects ... gut health and vascular health, the research findings presented ... of walnuts, inner workings. Running March 28 through April ... meeting attracts an international audience of over 14,000 leading ...

(Date:3/30/2015)... US-Australian drug discovery company, Novogen Ltd, (ASX:NRT; ... and Yale University, on March 27 released pre-clinical data ... as an oral presentation by Professor Gil Mor ... 62 nd Annual Scientific Meeting of the Society ... In both in vitro and ...

(Date:3/30/2015)... OTTAWA , March 30, 2015 /CNW/ - A ... today on the salaries and demographic profiles of new ... "Opening the Door – Building Careers for New Grads ... Canada,s Research-Based Pharmaceutical Companies (Rx&D) and features ... federal Career Focus wage subsidy program from 2013 to ...

... Oct. 18 Pharmion Corporation,(Nasdaq: PHRM ) will ... 31, 2007, after the close of the U.S. financial ... live audio,webcast to discuss the company,s results in greater ... 31, 2007. This call is being webcast by ...

... CLARA, Calif., Oct. 18 Coherent, Inc.,(Nasdaq: COHR ... after the market close and host a live webcast ... Wednesday, November 7,2007 at 4:30 p.m. ET. The ... can be accessed,at either http://www.coherent.com/Investors/ or ...

... KNOXVILLEThe National Science Foundation (NSF) has awarded $18.6 million ... Institute for Mathematical and Biological Synthesis (NIMBioS) to continue ... problems across biology, from the level of the genome ... next five years and renews the work of the ...

... a body is like building a houseif you compromise structural ... a cellular level than in the case of epithelial sheets, ... the gut to mammary glands. As long as epithelial cells ... of building tissue barriers and constructing ducts goes smoothly. But ...

... published in the July 17, issue of the journal ... forests in Malaysian Borneo have been heavily impacted by logging. ... were already thought to be global hotspots of forest loss ... the rates and patterns of change have remained poorly measured ...

... the only PCR system that ensures successful ... It provides accuracy, consistency, and dependability for ... property of the DNA templates. This system ... unique blend of thermostable enzymes that is ...

... C2C12 cells were cultured in DMEM and harvested ... order to keep the antigens in their native ... cells are arrayed on a 12-well (5 mm) ... treated to enhance cellular attachment and to minimize ...